William Shepard, a director atCME Group (CME), recently bought 294 shares. The buy increased his stake by about 1%, and came to a total cost of $63,231. This is Shepard’s second buy of the year, following a 1,390 share buy in January for $281,368. Shepard was a repeat buyer last year, and other company directors were buyers in 2022. Otherwise, CME Group executives have been regular sellers of shares. Overall, CME Group insiders own 0.5% of shares. The stock and financial exchange owner is up 13% in the past year, lagging the overall market. That’s in spite of a 19% jump in revenue...
More








